摘要
甲状腺功能亢进症是临床常见的内分泌代谢疾病,发病率逐年上升,病程缠绵,累及全身多个系统,在中医学归属于“瘿病”范畴。刘怀珍主任是江淮名中医,从事临床、科研工作30载,阅读大量医学文献,结合自身经验,对中西医治疗甲亢有独到见解。她认为甲亢发病多源于肝失疏泄,气郁化火。病位在肝,常累及心脾肾,病属本虚标实,本虚多为阴虚,标实多与气火痰瘀相关,提出疏肝养阴,兼顾清热、化痰、活血的治疗原则,自制柴芍二至散,随证加减,灵活变通,广泛应用于临床,取得良好的疗效,对改善患者的生活质量,减少并发症、改善预后有着重要的意义,为临床治疗甲亢提供一定了思路。该文通过总结刘主任治疗经验,并附病案一则,供广大读者借鉴与参考。
Hyperthyroidism is a common endocrine and metabolic disease,which incidence is increasing year by year,and the course of the disease is long and involves many systems.Hyperthyroidism belongs to gall in Chinese medicine。Liu huaizhen is a famous doctor of traditional Chinese medicine,who has been engaged in clinical and scientific research for 30 years,She read a large number of medical literature,combined with her own experience,has unique views on the treatment of hyperthyroidism in traditional Chinese and western medicine.Liu Huaizhen thinks that hyperthyroidism caused by the liver loses its ability to balance qi mostly.The qi stagnates and turns the fire,often cause liver Yin deficiency,kidney,involving the lungs disease belong to mark this virtual to real,the hollow than for the Yin deficiency,the real much related to the gas fire phlegm and blood stasis。Director liu proposed the treatment principles of nourishing Yin,promoting qi,clearing heat,resolving phlegm and promoting blood circulation。He has developed Chaishao Erzhi Powder with the addition and subtraction,and theclinical evidence is significant.It is of great significance to improve the quality of life of patients,reduce complications and improve the prognosis,providing certain ideas for the clinical treatment of hyperthyroidism.This article summarizes director Liu's treatment experience,and a medical record is attached for readers to learn and reference.
作者
王瑛瑛
刘怀珍
WANG Yingying;LIU Huaizhen(Anhui University of Chinese Medicine,Anhui Hefei 230038,China;The First Affiliated Hospital of Anhui University of Chinese Medicine,Anhui Hefei 230031,China)
出处
《中医药临床杂志》
2019年第12期2229-2232,共4页
Clinical Journal of Traditional Chinese Medicine
基金
安徽省卫生计生委中医药科研计划项目(2016zy12)。